Development and characterization of a transdermal patch and an emulgel containing kanamycin intended to be used in the treatment of mycetoma caused by Actinomadura madurae

References

• Pinoy E. (1913). Actinomycoses and mycetoma. Bull Inst Pasteur, 11:929–38.
   Google Scholar
• Díaz-Sánchez G, Loyola-Zárate M, Morales-Barrera E, Padilla MC. (1998). Micetoma por Actinomadura madurae. Comunicación de un caso. Revista del Centro Dermatológico Pascua, 7(2):94–6.
   Google Scholar
• Liu A, Maender JL, Coleman N, Hsu S, Rosen T. (2008). Actinomycetoma with negative cultura: A therapeutic challenge. Dermatol. Online J, 14(4):5.
   PubMedGoogle Scholar
• Licón-Trillo A, Castro-Corona MA, Salinas-Carmona MC. (2003). Immunogenicity and biophysical properties of a Nocardia brasiliensis protease involved in pathogenesis of mycetoma. FEMS Immunol Med Microbiol, 37:37–44.
   PubMed Web of Science ®Google Scholar
• Arenas R. (1996). 104. MICETOMA. Dermatología. Atlas, diagnóstico y tratamiento. 2nd ed. Mexico: McGraw Hill Interamericana, 355–62.
   Google Scholar
• Douwes KE, Schmalzbauer E, Linde HJ, Reisberger EM, Fleischer K, Lehn N, . (2003). Branched filaments no fungus, ovoid bodies no bacteria: Two unusual cases of micetoma. J Am Acad Dermatol, 49:S170–3.
   PubMed Web of Science ®Google Scholar
• Lupi O, Tyring SK, McGinnis MR. (2005). Tropical dermatology: Fungal tropical diseases. J Am Acad Dermatol, 53:931–51.
   PubMed Web of Science ®Google Scholar
• Lavalle-Aguilar P, Padilla-Desgarennes MC, Pérez-Gutiérrez J, Rivera I, Reynoso-Rangel S. (2000). Micetomas por Actinomadura madurae en México. Revista del Centro Dermatológico Pascua, 9(1):19–24.
   Google Scholar
• Castrillón-Rivera L, Palma-Ramos A. (1997). Actinomadura. Revista del Centro Dermatológico Pascua, 6(1):27–39.
   Google Scholar
• Moylett EH, Pacheco SE, Brown-Elliott BA, Perry TR, Buescher ES, Birmingham MC, . (2003). Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis, 36(3):313–8.
   PubMed Web of Science ®Google Scholar
• Daw-Garza A, Welsh O, Said-Fernández S, Lozano-Garza HG, Waksman de Torres N, Rocha NC, . (2008). In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis. Antimicrob Agents Chemother, 52(4):1549–50.
   PubMed Web of Science ®Google Scholar
• Harada KI, Tomita K, Fujii K, Masuda K, Mikami Y, Yazawa K, . (2004). Isolation and structural characterization of siderophores, madurastatins, produced by a pathogenic Actinomadura madurae. J Antibiot, 57(2):125–35.
   PubMed Web of Science ®Google Scholar
• Rigopoulos D, Mavridou M, Nicolaidou E, Christofidou E, Antoniou C, Stratigos A, . (2000). Micetoma due to actinomycetes: A rare entity in Europe. Int J Dermatol, 39:557–8.
   PubMed Web of Science ®Google Scholar
• Palma-Ramos A, Hernández-León A, Castrillón-Rivera L, Padilla-Desgarennes MC, Cejudo-Uribe BL. (2000). Desarrollo de un emulgel con sulfato de kanamicina para el tratamiento de actinomicetomas causados por Actinomadura madurae. Revista Mexicana de Ciencias Farmacéutica, 4:7–10.
   Google Scholar
• Palma RA, Hernández LA, Mejía BI, Castrillón RL, Padilla DC, Cejudo UBL. (2005). Control de calidad de un lote de emulgel con kanamicina, utilizado como auxiliar en el tratamiento de micetomas por Actinomadura madurae. Revista Mexicana de Ciencias Farmacéuticas, 36(2):16–25.
   Google Scholar
• Abdalla OAA, El Sir AMA. (1998). Unexpected high prevalence of secondary bacterial infection in patients with mycetoma. J Clin Microbiol, 36(3):850–1.
   PubMed Web of Science ®Google Scholar
• Steigbigel NH. (1995). Macrolides and clindamycin. In: Mandell GL, Benett JE, Dolin R, eds. Douglas and Bennett’s principles and practice of infection diseases. 4th ed. New York: Churchill Livingstone, 334–46.
   Google Scholar
• Molavi A, Weinstein L. (1971). In-vitro activity of erythromycin against atypical mycobacteria. J Infect Dis, 123:216–9.
   PubMed Web of Science ®Google Scholar
• The United States Pharmacopeia 24 and National Formulary 19 (USP XXIV). (2000). United States Pharmacopeia, Inc., Rockville.
   Google Scholar
• Castro-Rios R, Quintanar-Guerrero D, Ganem-Rondero, A. (1993). Diseño y evaluación de un ungüento antimicótico de liberación prolongada por una nueva técnica de adsorción-dispersión. Tesis de Licenciatura. UNAM-Facultad de Estudios Superiores Cuautitlán. Cuautitlán, 25–7.
   Google Scholar
• Padula C, Colombo G, Nicoli S, Catellani PL, Massimo G, San P. (2003). Bioadhesive film for the transdermal delivery of lidocaine: In vitro and in vivo behavior. J Control Rel, 88:277–85.
   PubMed Web of Science ®Google Scholar
• López-Cervantes M, Ganem-Rondero A. (2003). Estudio del efecto del Laurocapram (Azona®) y 4-Deciloxazolidon 2-ona (Dermac®) sobre la barrera de permeabilidad de la piel mediante pruebas de infrarrojo, pérdida de agua transepidermal y estudios de permeación in vitro. Tesis de Maestría. UNAM-Facultad de Estudios Superiores Cuautitlán. Cuautitlán.
   Google Scholar
• Mathiowitz, E, ed. (1999). Release kinetics, data interpretation. In: Encyclopedia of controlled drug delivery, vol. 1. New York: John Wiley & Sons, Inc., 921–30.
   Google Scholar
• Grassi M, Grassi G. (2005). Mathematical modelling and controlled drug delivery: Matrix systems. Curr Drug Deliv, 2:97–116.
   PubMedGoogle Scholar
• Brummer R, ed. (2006). 5 Basic physical and mathematical principles. In: Rheology essentials of cosmetic and food emulsion. 1st ed. Hamburg: Springer, 25–49.
   Google Scholar
• Kilcast D, ed. (2004). Measuring consumer perceptions of texture: An overview. In: Texture in food. vol. 2: Solid foods. 1st ed. Cornwall: CRC Press, 13–20.
   Google Scholar
• Tight RR, Bartlett MS. (1981). Actinomycetoma in the United States. Rev Infect Dis, 3(6):1139–50.
   PubMedGoogle Scholar
• Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, . (2004). Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: A randomized, double-bind, multicentre study. J Antimicrob Chemother, 53(2):345–55.
   PubMed Web of Science ®Google Scholar
• Ramam M, Bhat R, Garg T, Sharma VK, Ray R, Singh MK, . (2007). A modified two-step treatment for actinomycetoma. Indian J Dermatol Venereol Leprol, 73:235–9.
   PubMed Web of Science ®Google Scholar
• Pena LE. (1990). Gel dosage forms: Theory, formulation, and processing. In: Osborne DW, Amann AH, eds. Topical drug delivery formulations. New York: Marcel Dekker, Inc., 381–8.
   Google Scholar
• Faivre V. (2004). Aspects théoriques de la bioadhésion. In: Falson-Rieg F, Faivre V, Pirot F, eds. Nouvelles formes médicamenteuses. Paris: Editions Médicales Internationales, 1–24.
   Google Scholar
• Martini MCl. (2003). Formes galéniques. In: Introduction à la dermopharmacie et à la cosmétologie. Paris: Editions Medicales Intérnationales, 333–53.
   Google Scholar
• Lorette G, Vaillant L. (1995). Traitements locaux en dermatologie. Paris: Doin éditeurs, 1–233.
   Google Scholar
• Surber Ch, Tassopoulos T, Smith EW. (2002). Ointments, creams, and lotions used as topical drug delivery vehicles. In: Bronaugh RL, Maibach HI, eds. Topical absorption of dermatological products. New York: Marcel Dekker, Inc., 511–7.
   Google Scholar
• Bernad-Bernad MJ, Ganem-Rondero A, Melgoza-Contreras LM, Quintanar-Guerrero D. (2003). Sistemas de liberación controlada de activos farmacéuticos. Asociación Farmacéutica Mexicana, A.C., 94–105.
   Google Scholar
• Falson-Rieg F, Pirot F. (2004). Dispositifs transdermiques. In: Falson-Rieg F, Faivre V, Pirot F, eds. Nouvelles formes médicamenteuses. Paris: Editions Médicales Internationales, 1–24.
   Google Scholar